$Augmedix (AUGX.US)$ dropped from next quarter revenue guida...
$Augmedix(AUGX.US$ dropped from next quarter revenue guidance decrease in quarterly report. Looks like a buy as company expects the change from Live medical documentation review to AI documentation review to be positive in long run, transition to a SaaS company. Waiting to see the bottom and then potentially going in once Ive got cash back from $Scorpius Holdings(SCPX.US$ swing trade
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment